SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

 

 

Pursuant to Section 13 or 15(d) of the

 

Securities Exchange Act of 1934

 

 

 

Date of Report (Date of earliest event reported)                               October 30, 2002                     

 

 

Specialty Laboratories, Inc.

(Exact name of registrant as specified in charter)

 

 

 

 

 

 

 

 

Registrant’s telephone number, including area code                          (310) 828-6543                     

 

 

 

 

	(Former name or former address, if changed since last report.)

 

 

 

 

ITEM 9                   REGULATION FD DISCLOSURE

On October 30, 2002, Specialty Laboratories, Inc. (the “Registrant”) filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2002 (the “Report”) with the Securities and Exchange Commission.  Accompanying such Report were certifications of Specialty Laboratories Inc.’s Chief Executive Officer, Douglas S. Harrington, and Chief Financial Officer, Frank J. Spina, pursuant to 18 U.S.C. § 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.  The text of each of these certifications is set forth below:

Certification of Chief Executive Officer and Chief Financial Officer
pursuant to 18 U.S.C. § 1350 adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002

I, Douglas S. Harrington, Chief Executive Officer of Specialty Laboratories, Inc. (the “Company”), certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The report of the Company on Form 10-Q for the quarterly period ending September 30, 2002, as filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Douglas S. Harrington

Douglas S. Harrington

Chief Executive Officer
October 30, 2002

 

I, Frank J. Spina, Chief Financial Officer of Specialty Laboratories, Inc. (the “Company”), certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The report of the Company on Form 10-Q for the quarterly period ending September 30, 2002, as filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Frank J. Spina

Frank J. Spina

Chief Financial Officer
October 30, 2002

 

 

2

 

 

 

SIGNATURE

 

                Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

	Specialty Laboratories, Inc.
Date:  October 30, 2002	By:	/s/  FRANK J. SPINA
		Frank J. Spina, Chief Financial Officer

 

 

3